Safe Save Medical Cell Science & Technology Co., Ltd. (SSC)
A pioneer in immune cell therapy in Taiwan, SSC was founded in 2011 committed to research and development of immune cell therapy and innovative regimens to be applied to cancer, infection and immune diseases. Our mission is to offer effective, safe, and affordable therapy to the society.
Our flagship product is an in-house developed immune cell therapy product - Autologous Dendritic Cell/ Tumor Antigen Immunotherapy (ADCTA) for the treatment of cancer. The first indication of ADCTA is for the treatment of malignant brain tumors (GBM) and is the first and only immune cell therapeutic product approved by the Ministry of Health and Welfare to enter the phase III clinical trials in Taiwan.
We focus on R&D, manufacturing and offering of immune cell therapy and welcome cooperation in:
1. Clinical trial
2. Immune cell storage
3. Clinical application under regulations of specific medical examination techniques and medical devices
4. Licensing of products and know-how